stella
beta
A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC Patients — Stella
Recruiting
Back to NSCLC trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
The Hunan Cancer Hospital, Changsha, Hunan
View full record on ClinicalTrials.gov